A recent genome-wide association study among 699 children with acute lymphoblastic leukemia revealed that rs2306283 was associated with increased methotrexate (MTX, also substrates of SLCO1B1) clearance after adjusting for rs4149056[37]. Here, SLCO1B1 is linked to acute lymphoblastic leukemia.